Kiwa Bio-Tech Products Group Corp - ESG Rating & Company Profile powered by AI
If you work at Kiwa Bio-Tech Products Group Corp and you would like to licence your ESG rating, please get in touch. Check the end of the page for potential risks for Kiwa Bio-Tech Products Group Corp based on industry, geography and marketcap. Other companies in the rating peer group for Kiwa Bio-Tech Products Group Corp are displayed.
Kiwa Bio-Tech Products Group Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Kiwa Bio-Tech Products Group Corp | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Kiwa Bio-Tech Products Group Corp have an accelerator or VC vehicle to help deliver innovation?
Does Kiwa Bio-Tech Products Group Corp disclose current and historical energy intensity?
Does Kiwa Bio-Tech Products Group Corp report the average age of the workforce?
Does Kiwa Bio-Tech Products Group Corp reference operational or capital allocation in relation to climate change?
Does Kiwa Bio-Tech Products Group Corp disclose its ethnicity pay gap?
Does Kiwa Bio-Tech Products Group Corp disclose cybersecurity risks?
Does Kiwa Bio-Tech Products Group Corp use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does Kiwa Bio-Tech Products Group Corp offer flexible work?
Does Kiwa Bio-Tech Products Group Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Kiwa Bio-Tech Products Group Corp disclose the number of employees in R&D functions?
Does Kiwa Bio-Tech Products Group Corp plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does Kiwa Bio-Tech Products Group Corp conduct supply chain audits?
Does Kiwa Bio-Tech Products Group Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Kiwa Bio-Tech Products Group Corp conduct 360 degree staff reviews?
Does Kiwa Bio-Tech Products Group Corp disclose the individual responsible for D&I?
Does Kiwa Bio-Tech Products Group Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Kiwa Bio-Tech Products Group Corp disclose current and / or historical scope 2 emissions?
Does Kiwa Bio-Tech Products Group Corp disclose water use targets?
Does Kiwa Bio-Tech Products Group Corp have careers partnerships with academic institutions?
Did Kiwa Bio-Tech Products Group Corp have a product recall in the last two years?
Does Kiwa Bio-Tech Products Group Corp disclose incidents of discrimination?
Does Kiwa Bio-Tech Products Group Corp allow for Work Councils/Collective Agreements to be formed?
Has Kiwa Bio-Tech Products Group Corp issued a profit warning in the past 24 months?
Does Kiwa Bio-Tech Products Group Corp disclose parental leave metrics?
Does Kiwa Bio-Tech Products Group Corp disclose climate scenario or pathway analysis?
Does Kiwa Bio-Tech Products Group Corp disclose current and / or historical scope 1 emissions?
Does Kiwa Bio-Tech Products Group Corp explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does Kiwa Bio-Tech Products Group Corp disclose the pay ratio of women to men?
Does Kiwa Bio-Tech Products Group Corp support suppliers with sustainability related research and development?
Does Kiwa Bio-Tech Products Group Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Kiwa Bio-Tech Products Group Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Kiwa Bio-Tech Products Group Corp involved in embryonic stem cell research?
Does Kiwa Bio-Tech Products Group Corp disclose GHG and Air Emissions intensity?
Does Kiwa Bio-Tech Products Group Corp disclose its waste policy?
Does Kiwa Bio-Tech Products Group Corp report according to TCFD requirements?
Does Kiwa Bio-Tech Products Group Corp plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does Kiwa Bio-Tech Products Group Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Kiwa Bio-Tech Products Group Corp disclose energy use targets?
Does Kiwa Bio-Tech Products Group Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Kiwa Bio-Tech Products Group Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for Kiwa Bio-Tech Products Group Corp
These potential risks are based on the size, segment and geographies of the company.